Cargando…
A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort
BACKGROUND: The prognosis for pancreatic cancer remains poor despite diagnostic advances and treatments with new chemotherapeutic regimens. The five year survival rate remains below 3%. Consequently, there is an urgent need for new treatments to significantly improve the prognosis. In addition, ther...
Autores principales: | Canivet, Cindy, Gourgou-Bourgade, Sophie, Napoléon, Bertrand, Palazzo, Laurent, Flori, Nicolas, Guibert, Pierre, Piessen, Guillaume, Farges-Bancel, Dominique, Seitz, Jean-François, Assenat, Eric, Vendrely, Véronique, Truant, Stéphanie, Vanbiervliet, Geoffroy, Berthelémy, Philippe, Garcia, Stéphane, Gomez-Brouchet, Anne, Buscail, Louis, Bournet, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191891/ https://www.ncbi.nlm.nih.gov/pubmed/30326968 http://dx.doi.org/10.1186/s12885-018-4906-4 |
Ejemplares similares
-
A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score
por: Maulat, Charlotte, et al.
Publicado: (2020) -
Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapy
por: Buscail, Louis, et al.
Publicado: (2022) -
Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Frere, Corinne, et al.
Publicado: (2020) -
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
por: Bournet, Barbara, et al.
Publicado: (2016) -
Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
por: Amintas, Samuel, et al.
Publicado: (2021)